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Table 1. Toxicity encountered in patients with BTC undergoing
chemotherapy with MMC and 5-FU + FA.
Grade I n in rv
Leukopenia
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Anemia
Stomatis
Diarrhoea
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3
Additional toxicity included a mild syndrome of micro-angiopathic
anaemia seen in blood smear in one case.
a 40% RR [4]. In the second study, from Gustave Roussy, 19
patients with BTC were treated with 5-FU C.I. x 5 days com-
bined with cisplatin. A 32% RR with tolerable toxicity was
reported [5]. In summary, although definitive conclusions as
to the efficacy of the regimen employed in the present study
cannot be drawn, we suggest that further studies in BTC with
5-FU biologically modulated by FA or other agents are war-
ranted.
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Palliative care versus euthanasia?
In the otherwise admirable paper 'Palliative and supportive
care: At the frontier of medical omnipotence', I found the fol-
lowing statement unsettling: "Another consequence could be
that their alienation would lead them to indoctrination by
extreme groups who oppose the present medical system. In
some countries, such as Switzerland, proponents of physi-
cian-assisted suicide have tried to open independent 'health
care' structures to pursue their goals. An increased empo-
werment of these movements by traditional health care pro-
viders would have considerable and dangerous consequences
for the care and the rights of the weak and incapacitated
members of our societies" [1].
Do the authors mean that doctors (and in particular
oncologists) who are in favor of "physician-assisted-suicide"
or even euthanasia, are dangerous people? If so, for whom?
Perhaps only for those who are specialized in palliative care,
who seem increasingly to be creating artificial contention
between improvement in palliative care and the right of pa-
tients to opt for euthanasia, perhaps since they tend to view a
patient's desire for death as a demonstration of their own
failure. I am struck by how the authors, like other specialists
in palliative care, tend to avoid discussion and confrontation
with ethicists, who have clearly stated why patients have a
right to claim euthanasia and why morally it is difficult to
justify a denial of this right [2].
Discussion of this highly sensitive topic should be based
on philosophical and ethical considerations, and not on pre-
judice or competitive impulses.
C. Sessa
Division of Oncology, Ospedale San Giovanni, Bellin-
zona, Switzerland
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This letter was referred to the authors,
who respond as follows:
We agree that our sentences cited by C. Sessa are somehow
detached from the topic of the manuscript and that any dis-
cussion of this highly sensitive topic should be placed in a
broader context that includes philosophical and ethical con-
siderations. We do not consider doctors who are in favor of
physician-assisted suicide per se as dangerous people. We
only stated in the manuscript, that extreme groups exist out-
side the medical community who's only goal is to spread the
ideas of physician-assisted suicide and active euthanasia.
Most of these people are not physicians and some of them
have never been exposed to patients. In fact, we consider
such groups that are removed from any comprehensive view
of a medical patient as dangerous. We hope that the readers
did not share the opinion of Sessa, that we tend to concep-
tualize a patient's desire for death as a demonstration of our
own failure. In contrary, in the whole manuscript we tried to
illustrate how important a reflection of our own medical limi-
tations is. We believe that mutual reproaches and insinua-
tions will not advance the discussion to a deeper understand-
ing of this topic. Both 'camps', those who are in favor and
those who are opposed to physician-assisted suicide and/or
active euthanasia, claim to respect the dignity of mankind; we
hope that this respect will also find an expression in future
discussions of the topic.
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